Filing Details
- Accession Number:
- 0001209191-16-111003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-30 13:07:15
- Reporting Period:
- 2016-03-29
- Filing Date:
- 2016-03-30
- Accepted Time:
- 2016-03-30 13:07:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1626971 | Corvus Pharmaceuticals Inc. | CRVS | () | G7 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1388325 | A/S Novo | Tuborg Havnevej 19 Hellerup G7 2900 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-03-29 | 2,130,492 | $0.00 | 2,130,492 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2016-03-29 | 356,888 | $0.00 | 2,487,380 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2016-03-29 | 666,666 | $15.00 | 3,154,046 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2016-03-29 | 2,130,492 | $0.00 | 2,130,492 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2016-03-29 | 356,888 | $0.00 | 356,888 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- The Series A Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") had no expiration date. Upon the closing of the Issuer's initial public offering, the Preferred Stock automatically converted on a one-for-one basis for no additional consideration into common stock.
- Represents a purchase from the underwriters in the Issuer's public offering.
Billionaire Hedge Funds
